세계의 발기부전 치료기 시장 보고서(2025년)
Erectile Dysfunction Devices Global Market Report 2025
상품코드 : 1704299
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

발기부전 치료기 시장 규모는 향후 수년간 빠르게 성장하여 2029년까지 연평균 12.6%의 연평균 복합 성장률(CAGR)로 33억 9,000만 달러에 달할 것으로 예상됩니다. 예측 기간 중의 성장은 발기부전 유병률 증가, 개인 맞춤형 치료에 대한 관심 증가, 원격의료 및 원격 진료의 확대, 의료 정책 및 보험 적용에 대한 지지 증가, 비침습적 치료 옵션 증가 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 통합 모니터링 기능을 갖춘 스마트 기기의 개발, 저침습적 치료의 채택, 재택 치료 옵션의 채택, 생체 적합성 재료의 발전, 개인 맞춤형 치료를 위한 인공지능의 통합 등을 들 수 있습니다.

전립선암의 유병률 증가는 발기부전치료제 시장의 성장을 가속할 것으로 예상됩니다. 전립선암은 방광 아래에 있는 작은 기관으로 정액의 일부를 생성하는 역할을 하는 전립선에 발생하며, 상당수의 남성이 앓고 있습니다. 전립선암 환자 증가는 인구의 고령화, 더 나은 감지 방법 및 이 질병의 유병률에 영향을 미칠 수 있는 생활습관 요인과 관련이 있습니다. 발기부전 치료제는 전립선암 환자에게 매우 중요합니다. 발기 능력에 영향을 미치는 치료 후 성기능을 회복하고 삶의 질을 향상시키는 데 도움이 되기 때문입니다. 예를 들어 Cancer Australia는 2024년 1월, 2022년 호주에서 약 2만 4,217명의 신규 전립선암 환자가 발생할 것으로 예상되며, 2022년 남성이 85세까지 전립선암 진단을 받을 확률은 6명 중 1명(17%)으로 추산된다고 발표했습니다. 연령표준화 이환율은 남성 10만 명당 151명, 85세까지 전립선암으로 사망할 위험은 55명 중 1명(1.8%)으로 예측되었습니다. 따라서 전립선암 유병률 증가는 발기부전치료제 시장의 성장에 박차를 가하고 있습니다.

발기부전 치료기 시장의 주요 업체들은 경쟁 우위를 확보하기 위해 첨단 비침습적 제품 개발에 주력하고 있습니다. 비침습적 발기부전 치료기는 외과적 개입 없이 발기 기능을 개선하거나 회복하도록 설계된 의료 툴로, 종종 진공 요법, 전기 자극, 비침습적 음경 임플란트 등의 방법을 사용합니다. 예를 들어 2024년 6월 이스라엘의 의료기기 제조업체인 Oh Med Medical은 발기부전을 위한 VerticaPlus 장비를 발표했습니다. 이 혁신적인 장비에는 클라우드 기반 모바일 앱이 포함되어 있으며, 실시간 피드백 및 품질 추적을 통해 치료 경험을 향상시킵니다. 업그레이드 버전에서는 앱이 개인 코치 역할을 하며 지속적인 피드백, 단계별 튜토리얼, 보다 효과적인 치료를 위한 맞춤형 설정을 제공합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Erectile dysfunction devices are medical instruments intended to assist individuals with erectile dysfunction (ED) in achieving and sustaining an erection adequate for sexual activity. These devices utilize various methods, including suction, constriction, or medication delivery, to enhance blood flow to the penis or support its firmness.

There are two primary types of erectile dysfunction devices non-surgical and surgical. Non-surgical devices are designed to help men achieve and maintain an erection without the need for surgery. They are used to address conditions such as diabetes, neurological disorders, and hypertension, and can be either invasive or non-invasive. These devices cater to different age groups-under 40 years, 40-60 years, and over 60 years-and are utilized by various end-users including hospitals, clinics, ambulatory surgical centers, and others.

The erectile dysfunction devices market research report is one of a series of new reports from The Business Research Company that provides erectile dysfunction devices market statistics, including erectile dysfunction devices industry global market size, regional shares, competitors with a erectile dysfunction devices market share, detailed erectile dysfunction devices market segments, market trends and opportunities, and any further data you may need to thrive in the erectile dysfunction devices industry. This erectile dysfunction devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The erectile dysfunction devices market size has grown rapidly in recent years. It will grow from $1.87 billion in 2024 to $2.11 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to an increase in awareness of erectile dysfunction, an increase in acceptance of treatment options, an increase in the aging population, a rise in high prevalence of chronic conditions, increase in improvements in device safety and efficacy.

The erectile dysfunction devices market size is expected to see rapid growth in the next few years. It will grow to $3.39 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to the rising prevalence of erectile dysfunction, increasing focus on personalized treatments, growing telemedicine and remote consultations, a rise in supportive healthcare policies and insurance coverage, and increasing non-invasive treatment options. Major trends in the forecast period include the development of smart devices with integrated monitoring, the adoption of minimally invasive treatments, the adoption of home-based treatment options, advancements in biocompatible materials, and the integration of artificial intelligence for personalized care.

The rising prevalence of prostate cancer is expected to drive the growth of the erectile dysfunction devices market. Prostate cancer, originating in the prostate gland-a small organ below the bladder responsible for producing part of semen-affects a significant number of men. The increase in prostate cancer cases is linked to aging populations, better detection methods, and lifestyle factors that may influence the disease's prevalence. Erectile dysfunction devices are crucial for prostate cancer patients, as they help restore sexual function and enhance quality of life after treatment, which can often affect erectile capabilities. For instance, Cancer Australia reported in January 2024 that approximately 24,217 new prostate cancer cases were projected for Australia in 2022. Men in 2022 had an estimated 1 in 6 (17%) chance of being diagnosed with prostate cancer by age 85. The age-standardized incidence rate was expected to be 151 cases per 100,000 males, with a 1 in 55 (1.8%) risk of death from prostate cancer by age 85. Hence, the increasing prevalence of prostate cancer is fueling the growth of the erectile dysfunction devices market.

Leading companies in the erectile dysfunction devices market are focusing on developing advanced, non-invasive products to gain a competitive edge. Non-invasive erectile dysfunction devices are medical tools designed to improve or restore erectile function without surgical intervention, often using methods such as vacuum therapy, electrical stimulation, or non-penetrative penile implants. For example, in June 2024, Ohh Med Medical, an Israel-based medical equipment manufacturer, introduced the VerticaPlus device for erectile dysfunction. This innovative device includes a cloud-based mobile app that enhances the therapy experience with real-time feedback and quality tracking. The upgraded version features the app as a personal coach, offering ongoing feedback, step-by-step tutorials, and customized settings for more effective therapy.

In September 2022, Advanced MedTech Holdings, a Singapore-based medical technology company, acquired WIKKON for an undisclosed amount. This acquisition strengthens AMTH's position in China and expands its global urology platform, combining WIKKON's innovative technology with AMTH's resources to better serve both domestic and international markets. WIKKON, based in China, specializes in solutions for treating erectile dysfunction.

Major companies operating in the erectile dysfunction devices market are Boston Scientific Corporation, Medline Industries LP, Coloplast Corporation, Hollister Incorporated, MTS Medical AG, Alma Lasers Ltd., Owen Mumford Ltd., Shenzhen Huikang Medical Apparatus Co. Ltd., Storz Medical AG, UroMatrix Medical Systems, Medispec Ltd., Zephyr Surgical Implants, Timm Medical Technologies Inc., Promedon GmbH, Zimmer MedizinSysteme GmbH, Mercury Healthcare Pvt. Ltd., Rigicon Inc., NOVAmedtek, Tyna International Ltd., Vacurect, The Elator, Pos-T-Vac Medical Inc., Silimed Industria de Implantes

North America was the largest region in the erectile dysfunction devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the erectile dysfunction devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the erectile dysfunction devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The erectile dysfunction devices market consists of sales of penile prostheses, injection therapy devices, urethral suppositories, and related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Erectile Dysfunction Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on erectile dysfunction devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for erectile dysfunction devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The erectile dysfunction devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Erectile Dysfunction Devices Market Characteristics

3. Erectile Dysfunction Devices Market Trends And Strategies

4. Erectile Dysfunction Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Erectile Dysfunction Devices Growth Analysis And Strategic Analysis Framework

6. Erectile Dysfunction Devices Market Segmentation

7. Erectile Dysfunction Devices Market Regional And Country Analysis

8. Asia-Pacific Erectile Dysfunction Devices Market

9. China Erectile Dysfunction Devices Market

10. India Erectile Dysfunction Devices Market

11. Japan Erectile Dysfunction Devices Market

12. Australia Erectile Dysfunction Devices Market

13. Indonesia Erectile Dysfunction Devices Market

14. South Korea Erectile Dysfunction Devices Market

15. Western Europe Erectile Dysfunction Devices Market

16. UK Erectile Dysfunction Devices Market

17. Germany Erectile Dysfunction Devices Market

18. France Erectile Dysfunction Devices Market

19. Italy Erectile Dysfunction Devices Market

20. Spain Erectile Dysfunction Devices Market

21. Eastern Europe Erectile Dysfunction Devices Market

22. Russia Erectile Dysfunction Devices Market

23. North America Erectile Dysfunction Devices Market

24. USA Erectile Dysfunction Devices Market

25. Canada Erectile Dysfunction Devices Market

26. South America Erectile Dysfunction Devices Market

27. Brazil Erectile Dysfunction Devices Market

28. Middle East Erectile Dysfunction Devices Market

29. Africa Erectile Dysfunction Devices Market

30. Erectile Dysfunction Devices Market Competitive Landscape And Company Profiles

31. Erectile Dysfunction Devices Market Other Major And Innovative Companies

32. Global Erectile Dysfunction Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Erectile Dysfunction Devices Market

34. Recent Developments In The Erectile Dysfunction Devices Market

35. Erectile Dysfunction Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기